Endogenous DOPA Inhibits Melanoma through Suppression of CHRM1 Signaling

Using primary human melanocytes representing the full human skin pigment continuum and preclinical melanoma models, the authors showed that cell-intrinsic differences between dark and light melanocytes regulated melanocyte proliferative capacity and susceptibility to malignant transformation.